Prevention and treatment of complications in pancreatic cancer surgery

Digestive Surgery

Volumn 16, Issue 4, 1999, Pages 327-336

  Berberat, Pascal O ^a   Friess, Helmut ^a   Kleeff, Jörg ^a   Uhl, Waldemar ^a   Büchler, Markus W ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Delayed gastric emptying; Fistulas; Hemorrhage; Octreotide; Pancreatic cancer surgery; Pancreatic resection; Postoperative complications

Indexed keywords

ANTIBIOTIC AGENT; OCTREOTIDE; SOMATOSTATIN;

ABDOMINAL ABSCESS; ANASTOMOSIS LEAKAGE; HUMAN; INTESTINE ANASTOMOSIS; INTRAVENOUS DRUG ADMINISTRATION; PANCREAS CANCER; PANCREAS FISTULA; PANCREAS HEMORRHAGE; PANCREATICODUODENECTOMY; POSTOPERATIVE COMPLICATION; REVIEW; SMALL INTESTINE; STOMACH; SUBCUTANEOUS DRUG ADMINISTRATION; SURGICAL MORTALITY; SURGICAL TECHNIQUE; VATER PAPILLA CARCINOMA;

ABDOMINAL ABSCESS; HUMANS; PANCREATECTOMY; PANCREATIC FISTULA; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; POSTOPERATIVE COMPLICATIONS; POSTOPERATIVE HEMORRHAGE;

EID: 0032764303     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000018743     Document Type: Review

References (105)

1. Parker SL, Tong T, Bolden S, Wingo PA: Cancer statistics, 1997. CA Cancer J Clin 1997;47: 5-27.
2. Gudjonsson B: Cancer of the pancreas. 50 years of surgery. Cancer 1987;60:2284-2303.
3. Bramhall SR, Neoptolemos JP: Adjuvant chemotherapy in pancreatic cancer. Int J Pancreatol 1997;21:59-63.
4. Nishimura Y, Hosotani R, Shibamoto Y, Kokubo M, Kanamori S, Sasai K, Hiraoka M, Ohshio G, Imamura M, Takahashi M, Abe M: External and intraoperative radiotherapy for resectable and unresectable pancreatic cancer: analysis of survival rates and complications. Int J Radiat Oncol Biol Phys 1997;39:39-49.
5. Friess H, Büchler M, Kruger M, Beger HG: Treatment of duct carcinoma of the pancreas with the LH-RH analogue Buserelin. Pancreas 1992;7:516-521.
6. Friess H, Büchler M, Beglinger C, Weber A, Kunz J, Fritsch K, Dennler HJ, Beger HG: Low-dose octreotide treatment is not effective in patients with advanced pancreatic cancer. Pancreas 1993;8:540-545.
7. Büchler M, Friess H, Schultheiss KH, Gebhardt C, Kubel R, Muhrer KH, Winkelmann M, Wagener T, Klapdor R, Kaul M: A randomized controlled trial of adjuvant immunotherapy (murine monoclonal antibody 494/32) in resectable pancreatic cancer. Cancer 1991;68: 1507-1512.
8. Tsuchiya R, Tsunoda T, Ishida T, Saitoh Y: Resection for cancer of the pancreas: The Japanese experience. Baillieres Clin Gastroenterol 1990;4:931-939.
9. Morrow M, Hilaris B, Brennan MF: Comparison of conventional surgical resection, radioactive implantation, and bypass procedures for exocrine carcinoma of the pancreas 1975-1980.Ann Surg 1984;199:1-5.
10. Trede M, Schwall G, Saeger HD: Survival after pancreatoduodenectomy, 118 consecutive resections without an operative mortality. Ann Surg 1990;211:447-458.
11. Cameron JL, Pitt HA, Yeo CJ, Lillemoe KD, Kaufman HS, Coleman J: One hundred and forty-five consecutive pancreaticoduodenectomies without mortality. Ann Surg 1993;217: 430-435.
12. Russell RC: Surgical resection for cancer of the pancreas. Baillieres Clin Gastroenterol 1990;4: 889-916.
13. Fortner JG: Regional resection and pancreatic carcinoma. Surgery 1973;73:799-800.
14. Yeo CJ, Cameron JL, Sohn TA, Lillemoe KD, Pitt HA, Talamini MA, Hruban RH, Ord SE, Sauter PK, Coleman J, Zahurak ML, Grochow LB, Abrams RA: Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: Pathology, complications, and outcomes. Ann Surg 1997;226:248-257.
15. Bottger TC, Junginger T: Factors influencing morbidity and mortality after pancreaticoduodenectomy: critical analysis of 221 resections. World J Surg 1999;23:164-171.
16. Trede M, Saeger HD, Schwall G, Rumstadt B: Resection of pancreatic cancer: Surgical achievements. Langenbecks Arch Surg 1998; 383:121-128.
17. Neoptolemos JP, Russell RC, Bramhall S, Theis B: Low mortality following resection for pancreatic and periampullary tumours in 1026 patients: UK survey of specialist pancreatic units. UK Pancreatic Cancer Group. Br J Surg 1997;84:1370-1376.
18. Bakkevold KE, Kambestad B: Morbidity and mortality after radical and palliative pancreatic cancer surgery. Risk factors influencing the short-term results. Ann Surg 1993;217:356-368.
19. Cullen JJ, Sarr MG, Ilstrup DM: Pancreatic anastomotic leak after pancreaticoduodenectomy: incidence, significance, and management. Am J Surg 1994;168:295-298.
20. Bartoli FG, Arnone GB, Ravera G, Bachi V: Pancreatic fistula and relative mortality in malignant disease after pancreaticoduodenectomy. Review and statistical meta-analysis regarding 15 years of literature. Anticancer Res 1991;11:1831-1848.
21. Friess H, Malfertheiner P, Isenmann R, Kuhne H, Beger HG, Büchler MW: The risk of pancreaticointestinal anastomosis can be predicted preoperatively. Pancreas 1996;13:202-208.
22. Al Sharaf Ch, Ishe I, Dawiskiba S, Andrén-Sanberg A: Characteristics of the gland remnant predict complications after subtotal pancreatectomy. Dig Surg 1997;14:101-106.
23. Büchler M, Friess H, Klempa I, Hermanek P, Sulkowski U, Becker H, Schafmayer A, Baca I, Lorenz D, Meister R: Role of octrwotide in the prevention of postoperative complications following pancreatic resection. Am J Surg 1992; 163:125-130.
24. Sato N, Yamaguchi K, Yokohata K, Shimizu S, Morisaki T, Mizumoto K, Chijiiwa K, Tanaka M: Preoperative exocrine pancreatic function predicts risk of leakage of pancreaticojejunostomy. Surgery 1998;124:871-876.
25. Sato N, Yamaguchi K, Chijiiwa K, Tanaka M: Risk analysis of pancreatic fistula after pancreatic head resection. Arch Surg 1998;133: 1094-1098.
26. Hamanaka Y, Nishihara K, Hamasaki T, Kawabata A, Yamamoto S, Tsurumi M, Ueno T, Suzuki T: Pancreatic juice output after pancreatoduodenectomy in relation to pancreatic consistency, duct size, and leakage. Surgery 1996;119:281-287.
27. Fourtanier E, Chipponi J, Fagniez PL, Hay JM, Haddad AE, Fingerhut A: Octreotide in the prevention of surgical complications after pancreatectomy. A prospective randomized multicenter study (abstract). Hepatogastroenterology 1998;45(suppl):A429.
28. Briceno Delgado FJ, Lopcz Cillero P, Rufian Pena S, Solozano Peck G, Fugarolas G, Pera Madrazo C: Prospective and randomized study on the usefulness of octreotide in the prevention of complications after cephalic duodeno-pancreatectomy. Rev Esp Enferm Dig 1998; 90:687-694.
29. Pederzoli P, Bassi C, Falconi M, Camboni MG: Efficacy of octreotide in the prevention of complications of elective pancreatic surgery. Italian Study Group. Br J Surg 1994;81:265-269.
30. Friess H, Begrr HG, Sulkowski U, Becker H, Hofbauer B, Dennler HJ, Büchler MW: Randomized controlled multicentre study of the prevention of complications by octreotide in patients undergoing surgery for chronic pancreatitis. Br J Surg 1995;82:1270-1273.
31. Montorsi M, Zago M, Mosca F, Capussotti E, Zotti E, Ribotta G, Fegiz G, Fissi S, Roviaro G, Peracchia A: Efficacy of octreotide in the prevention of pancreatic fistula after elective pancreatic resections: A prospective, controlled, randomized clinical trial. Surgery 1995;117: 26-31.
32. Lowy AM, Lee JE, Pisters PW, Davidson BS, Fenoglio CJ, Stanford P, Jinnah R, Evans DB: Prospective, randomized trial of octreotide to prevent pancreatic fistula after pancreaticoduodenectomy for malignant disease. Ann Surg 1997;226:632-641.
33. Biehl T, Traverso LW: Is stenting necessary for a successful pancreatic anastomosis? Am J Surg 1992;163:530-532.
34. Kingsnorth AN: Duct to mucosa isolated Roux loop pancreaticojejunostomy as an improved anastomosis after resection of the pancreas. Surg Gynecol Obstet 1989;169:451-453.
35. Kram HB, Clark SR, Ocampo HP, Yamaguchi MA, Shoemaker WC: Fibrin glue sealing of pancreatic injuries, resections, and anastomoses. Am J Surg 1991;161:479-481.
36. D'Andrea AA, Costantino V, Sperti C, Pedrazzoli S: Human fibrin sealant in pancreatic surgery: Is it useful in preventing fistulas? A prospective randomized study. Ital J Gastroenterol 1994;26:283-286.
37. Roder JD, Stein HJ, Bottcher KA, Busch R, Heidecke CD, Siewert JR: Stented versus nonstented pancreaticojejunostomy after pancreatoduodenectomy: A prospective study. Ann Surg 1999;229:41-48.
38. Gilsdorf RB, Spanos P: Factors influencing morbidity and mortality in pancreaticoduodenectomy. Ann Surg 1973;177:332-337.
39. Kingsnorth AN: Safety and function of isolated Roux loop pancreaticojejunostomy after Whipple's pancreaticoduodenectomy. Ann R Coll Surg Engl 1994;76:175-179.
40. Matsusue S, Takeda H, Nakamura Y, Nishimura S, Koizumi S: A prospective analysis of the factors influencing pancreaticojejunostomy performed using a single method, in 100 consecutive pancreaticoduodenectomies. Surg Today 1998;28:719-726.
41. Delcore R, Thomas JH, Pierce GE, Hermreck AS: Pancreatogastrostomy: A safe drainage procedure after pancreatoduodenectomy. Surgery 1990;108:641-645.
42. Kapur BM: Pancreaticogastrostomy in pancreaticoduodenal resection for ampullary carcinoma: Experience in thirty-one cases. Surgery 1986;100:489-493.
43. Mason GR, Freeark RJ: Current experience with pancreatogastrostomy. Am J Surg 1995; 169:217-219.
44. Icard P, Dubois F: Pancreaticogastrostomy following pancreatoduodenectomy. Ann Surg 1988;207:253-256.
45. Yeo CJ, Cameron JL, Maher MM, Sauter PK, Zahurak ML, Talamini MA, Lillemoe KD, Pitt HA: A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy. Ann Surg 1995;222:580-588.
46. Greene BS, Loubeau JM, Peoples JB, Elliott DW: Are pancreatoenteric anastomoses improved by duct-to-mucosa sutures? Am J Surg 1991;161:45-49.
47. Marcus SG, Cohen H, Ranson JH: Optimal management of the pancreatic remnant after pancreaticoduodenectomy. Ann Surg 1995; 221:635-645.
48. Crist DW, Sitzmann JV, Cameron JL: Improved hospital morbidity, mortality, and survival after the Whipple procedure. Ann Surg 1987;206:358-365.
49. Grace PA, Pitt HA, Longmire WP: Pancreatoduodenectomy with pylorus preservation for adenocarcinoma of the head of the pancreas. Br J Surg 1986;73:647-650.
50. Braasch JW, Deziel DJ, Rossi RL, Watkins E Jr. Winter PF: Pylorie and gastric preserving pancreatic resection. Experience with 87 patients. Ann Surg 1986;204:411-418.
51. Sikora SS, Posner MC: Management of the pancreatic stump following pancreaticoduodenectomy. Br J Surg 1995;82:1590-1597.
52. Andivot T, Cardoso J, Dousset B, Soubrane O, Bonnichon P, Chapuis Y: Complications of two types of pancreatic anastomosis after pancreaticoduodenectomy. Ann Chir 1996;50: 431-437.
53. Torres AJ, Landa JI, Morcno-Azcoita M, Arguello JM, Silecchia G, Castro J, Hernandez-Merlo F, Jover JM, Morcno-Gonzales E, Balibrea JL: Somatostatin in the management of gastrointestinal fistulas. A multicenter trial. Arch Surg 1992;127:97-99.
54. Sancho JJ, di Costanzo J, Nubiola P, Larrad A, Beguiristain A, Roqueta F, Franch G, Oliva A, Gubern JM, Sitges-Serra A: Randomized double-blind placebo-controlled trial of early octreotide in patients with postoperative enterocutaneous fistula. Br J Surg 1995;82:638-641.
55. van Berge Henegouwen MI, De Wit LT, van Gulik TM, Obertop H, Gouma DJ: Incidence, risk factors, and treatment of pancreatic leakage after pancreaticoduodenectomy: Drainage versus resection of the pancreatic remnant. J Am Coll Surg 1997;185:18-24.
56. Farley DR, Schwall G, Trede M: Completion pancreatectomy for surgical complications after pancreaticoduodenectomy. Br J Surg 1996; 83:176-179.
57. Yeo CJ: Management of complications following pancreaticoduodenectomy. Surg Clin North Am 1995;75:913-924.
58. Miedema BW, Sarr MG, van Heerden JA, Nagorney DM, Mcllrath DC, Ilstrap D: Complications following panereaticoduodenectomy. Current management. Arch Surg 1992;127: 945-949.
59. Rumstadt B, Schwab M, Korth P, Samman M, Trede M: Hemorrhage after pancreatoduodenectomy. Ann Surg 1998;227:236-241.
60. van Berge Henegouwen MI, Allema JH, van Gulik TM, Verbeek PC, Obertop H, Gouma DJ: Delayed massive haemorrhage after pancreatic and biliary surgery. Br J Surg 1995;82: 1527-1531.
61. Shankar S, Russell RC: Haemorrhage in pancreatic disease. Br J Surg 1989;76:863-866.
62. Meinke WB, Twomey PL, Guernsey JM, Frey CF, Farias LR, Higgins G, Keehn R: Gastrointestinal bleeding after operation for pancreatic cancer. Am J Surg 1983;146:57-60.
63. Pitt HA, Cameron JL, Postier RG, Gadacz TR: Factors affecting mortality in biliary tract surgery. Am J Surg 1981;141:66-72.
64. Dixon JM, Armstrong CP, Duffy SW, Elton RA, Davies GC: Upper gastrointestinal bleeding. A significant complication after surgery for relief of obstructive jaundice. Ann Surg 1984; 199:271-275.
65. Karsten TM, Allema JH, Reinders M, van Gulik TM, De Wit LT, Verbeek PC, Huibregtsc K, Tytgat GN, Gouma DJ: Preoperative biliary drainage, colonisation of bile and postoperative complications in patients with tumours of the pancreatic head: A retrospective analysis of 241 consecutive patients. Eur J Surg 1996;162: 881-888.
66. Brodsky JT, Turnbull AD: Arterial hemorrhage after pancreatoduodenectomy. The 'sentinel bleed'. Arch Surg 1991;126:1037-1040.
67. Greve JW, Maessen JG, Tiebosch T, Buurman WA, Gouma DJ: Prevention of postoperative complications in jaundiced rats. Internal biliary drainage versus oral lactulose. Ann Surg 1990;212:221-227.
68. Diamond T, Rowlands BJ: Endotoxaemia in obstructive jaundice. HPB Surg 1991;4:81-94.
69. Parks RW, Clements WD, Smye MG, Pope C, Rowlands BJ, Diamond T: Intestinal barrier dysfunction in clinical and experimental obstructive jaundice and its reversal by internal biliary drainage. Br J Surg 1996;83:1345-1349.
70. Marcus SG, Dobryansky M, Shamamian P, Cohen H, Gouge TH, Pachter HL, Eng K: Endoscopic biliary drainage before pancreaticoduodenectomy for periampullary malignancies. J Clin Gastroenterol 1998;26:125-129.
71. Smith RC, Pooley M, George CR, Faithful GR: Preoperativc percutaneous transhepatic internal drainage in obstructive jaundice: A randomized, controlled trial examining renal function. Surgery 1985;97:641-648.
72. Pitt HA, Gomes AS, Lois JF, Mann LL, Deutsch LS, Longmire WP, Jr.: Does preoperative percutaneous biliary drainage reduce operative risk or increase hospital cost? Ann Surg 1985;201:545-553.
73. Lai EC, Mok FP, Fan ST, Lo CM, Chu KM, Liu CL, Wong J: Preoperative endoscopic drainage for malignant obstructive jaundice (see comments). Br J Surg 1994;81:1195-1198.
74. van Berge Henegouwen MI, van Gulik TM, DeWit LT, Allema JH, Rauws EA, Obertop H, Gouma DJ: Delayed gastric emptying after standard pancreaticoduodenectomy versus pylorus-preserving pancreaticoduodenectomy: an analysis of 200 consecutive patients. J Am Coll Surg 1997;185:373-379.
75. Patel AG, Toyama MT, Kusske AM, Alexander P, Ashley SW, Reber HA: Pylorus-preserving Whipple resection for pancreatic cancer. Is it any better? Arch Surg 1995;130:838-842.
76. Zerbi A, Balzano G, Patuzzo R, Calori G, Braga M, Di Carlo V: Comparison between pylorus-preserving and Whipple pancreatoduodenectomy. Br J Surg 1995;82:975-979.
77. Yeo CJ, Cameron JL, Sohn TA, Coleman J, Sauter PK, Hruban RH, Pitt HA, Lillemoe KD: Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: Comparison of morbidity and mortality and short-term outcome (in process citation). Ann Surg 1999;229:613-622.
78. Pedrazzoli S, DiCarlo V, Dionigi R, Mosca F Pederzoli P, Pasquali C. Kloppel G, Dhaene K, Michelassi F: Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: A multicenter, prospective, randomized study. Lymphadenectomy Study Group. Ann Surg 1998;228:508-517.
79. Tanaka M, Sarr MG: Role of the duodenum in the control of canine gastrointestinal motility. Gastroenterology 1988;94:622-629.
80. Whipple AO, Pearson WB, Mullins CR: Treatment of carcinoma of the ampulla of Vater. Ann Surg 1935;102:763-769.
81. Traverso LW, Longmire WP Jr: Preservation of the pylorus in pancreaticoduodenectomy. SurgGynecol Obstet 1978;146:959-962.
82. Watson K: Carcinoma of the ampulla of Vater: successful radical resection. BrJ Surg 1944;31: 368-373.
83. Roder JD, Stein HJ, Huttl W, Siewert JR: Pylorus-preserving versus standard pancreaticoduodenectomy: an analysis of 110 pancreatic and periampullary carcinomas (see comments). Br J Surg 1992;79:152-155.
84. Klinkenbijl JH, van der Schelling GP, Hop WC, van Pel R, Banning HA, Jeekel J: The advantages of pylorus-preserving pancreatoduodenectomy in malignant disease of the pancreas and periampullary region. Ann Surg 1992;216:142-145.
85. Mosca F, Giulianotti PC, Balestracci T, Di Candio G, Pietrabissa A, Sbrana F, Rossi G: Long-term survival in pancreatic cancer: pylorus-preserving versus Whipple pancreatoduodenectomy. Surgery 1997;122:553-566.
86. Schoenberg MH, Gansauge F, Kunz R: Value of pylorus preserving partial duodenopancreatectomy in ductal pancreatic carcinoma. Chirurg 1997;68:1262-1267.
87. Seiler CA, Wagner M, Sadowski Ch, Kulli Ch, Büchler MW: Randomized prospective trial on pylorus preserving versus classic duodenopancreatectomy (Whipple): First clinical results. J Gastrointest Surg 1999, in press.
88. Sadowski C, Uhl W, Baer HU, Reber P, Seiler C, Büchler MW: Delayed gastric emptying after classic and pylorus-preserving whipple procedure: A prospective study. Dig Surg 1997;14: 159-164.
89. Lin PW, Lin YJ: Prospective randomized comparison between pylorus-preserving and standard pancreaticoduodcnectomy. Br J Surg 1999;86:603-607.
90. Manabe T, Ohshio G, Baba N, Miyashita T, Asano N, Tamura K, Yamaki K, Nonaka A, Tobe T: Radical pancreatectomy for ductal cell carcinoma of the head of the pancreas. Cancer 1989;64:1132-1137.
91. Ishikawa O, Ohhigashi H, Sasaki Y, Kabuto T, Fukuda I, Furukawa H, Imaoka S, Iwanaga T: Practical usefulness of lymphatic and connective tissue clearance for the carcinoma of the pancreas head. Ann Surg 1988;208:215-220.
92. Kayahara M, Nagakawa T, Ueno K, Ohta T, Tsukioka Y, Miyazaki I: Surgical strategy for carcinoma of the pancreas head area based on clinicopathologic analysis of nodal involvement and plexus invasion. Surgery 1995;117: 616-623.
93. Pellegrini CA, Heck CF, Raper S, Way LW: An analysis of the reduced morbidity and mortality rates after pancreaticoduodenectomy. Arch Surg 1989;124:778-781.
94. Trede M, Schwall G: The complications of pancreatectomy. Ann Surg 1988;207:39-47.
95. Raptis S, Schlegel W, Lehmann E, Dollinger HC, Zoupas C: Effects of somatostatin on the exocrine pancreas and the release of duodenal hormones. Metabolism 1978;27:1321-1328
96. Creutzfeldt W, Lankisch PG, Folsch UR: Inhibition by somatostatin of pancreatic juice and enzyme secretion and gallbladder con-traction in man induced by secretin and cholecystokinin-pancreozymin administration. Dtsch Med Wochenschr 1975;100:1135-1138.
97. Taparel D, Susini C, Esteve JP, Diaz J, Cazaubon C, Vaysse N, Ribet A: Somatostatin analogs: correlation of receptor affinity with inhibition of cyclic AMP formation in pancreatic acinar cells. Peptides 1985;6:109-114.
98. Klempa I, Schwedes U, Usadel KH: Prevention of postoperative pancreatic complications following duodenopancreatectomy using somatostatin. Chirurg 1979;50:427-431.
99. Starzl TE, Todo S, Tzakis A, Podesta L, Mieles L, Demetris A, Teperman L, Selby R, Stevenson W, Stieber A: Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies. Ann Surg 1989;210:374-385.
100. Daloze P, Beauregard H, St Louis G, Corman J, Smeesters C. Aris-Jilwain N, Comtois R, Rasio E: Clinical pancreas transplantation: a learning curve of its management. Transplant Proc 1989;21:2858-2861.
101. Kohler E, Beglinger C, Dettwiler S, Whitehouse I, Gyr K: Effect of a new somatostatin analogue on pancreatic function in healthy volunteers. Pancreas 1986;1:154-159.
102. Creutzfeldt W, Lembeke B, Folsch UR, Schleser S, Koop I: Effect of somatostatin analogue (SMS 201-995, Sandostatin) on pancreatic secretion in humans. Am J Med 1987; 82:49-54.
103. Büchler MW, Binder M, Friess H: Role of somatostatin and its analogues in the treatment of acute and chronic pancreatitis. Gut 1994;35(suppl):15.
104. Kemmer TP, Malfertheiner P, Büchler M, Friess H, Meschenmoser L, Ditschuncit H: Inhibition of human exocrine pancreatic secretion by the long-acting somatostatin analogue octreotide (SMS 201-995). Aliment Pharmacol Ther 1992;6:41-50.
105. Friess H, Bordihn K, Ebert M, Malfertheiner P, Kemmer T, Dennler HJ, Büchler MW: Inhibition of pancreatic secretion under long-term octreotide treatment in humans. Digestion 1994;55(suppl 1):10-15.